HEADER TRANSFERASE 29-JAN-20 6VNH TITLE JAK2 JH1 IN COMPLEX WITH PN2-123 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: EXPI293F; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCDNA 3.3 KEYWDS JANUS ASSOCIATED KINASE, JAK2, KINASE DOMAIN, JH1, KINASE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.R.DAVIS,E.SCHONBRUNN REVDAT 5 15-NOV-23 6VNH 1 REMARK REVDAT 4 11-OCT-23 6VNH 1 REMARK REVDAT 3 10-MAR-21 6VNH 1 JRNL REVDAT 2 24-FEB-21 6VNH 1 JRNL REVDAT 1 17-FEB-21 6VNH 0 JRNL AUTH R.R.DAVIS,B.LI,S.Y.YUN,A.CHAN,P.NAREDDY,S.GUNAWAN,M.AYAZ, JRNL AUTH 2 H.R.LAWRENCE,G.W.REUTHER,N.J.LAWRENCE,E.SCHONBRUNN JRNL TITL STRUCTURAL INSIGHTS INTO JAK2 INHIBITION BY RUXOLITINIB, JRNL TITL 2 FEDRATINIB, AND DERIVATIVES THEREOF. JRNL REF J.MED.CHEM. V. 64 2228 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33570945 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01952 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4092 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 66379 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.410 REMARK 3 FREE R VALUE TEST SET COUNT : 2261 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.4700 - 6.0400 1.00 4013 142 0.1575 0.1439 REMARK 3 2 6.0300 - 4.8000 1.00 3999 142 0.1918 0.2014 REMARK 3 3 4.8000 - 4.1900 1.00 4043 137 0.1861 0.2395 REMARK 3 4 4.1900 - 3.8100 1.00 4001 142 0.1944 0.2510 REMARK 3 5 3.8100 - 3.5400 1.00 4032 146 0.2061 0.2535 REMARK 3 6 3.5400 - 3.3300 1.00 4012 132 0.2302 0.2894 REMARK 3 7 3.3300 - 3.1600 1.00 4009 140 0.2707 0.3031 REMARK 3 8 3.1600 - 3.0200 1.00 4011 142 0.3091 0.4541 REMARK 3 9 3.0200 - 2.9100 1.00 4041 144 0.2897 0.3314 REMARK 3 10 2.9100 - 2.8100 0.99 3957 138 0.3068 0.3821 REMARK 3 11 2.8100 - 2.7200 1.00 3991 144 0.3224 0.3551 REMARK 3 12 2.7200 - 2.6400 0.99 4007 140 0.3431 0.3511 REMARK 3 13 2.6400 - 2.5700 1.00 3980 144 0.3622 0.3982 REMARK 3 14 2.5700 - 2.5100 0.99 4025 138 0.3789 0.4129 REMARK 3 15 2.5100 - 2.4500 1.00 4052 146 0.3928 0.4444 REMARK 3 16 2.4500 - 2.4000 0.99 3945 144 0.4329 0.4411 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.480 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 68.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VNH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1000246382. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK DOUBLE-CRYSTAL REMARK 200 SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66379 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 43.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2XA4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5, 0.2 M NACL, 25% REMARK 280 PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.28250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.64125 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 52.92375 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS B 825 REMARK 465 HIS B 826 REMARK 465 HIS B 827 REMARK 465 HIS B 828 REMARK 465 HIS B 829 REMARK 465 HIS B 830 REMARK 465 HIS B 831 REMARK 465 HIS B 832 REMARK 465 GLU B 833 REMARK 465 ASN B 834 REMARK 465 LEU B 835 REMARK 465 TYR B 836 REMARK 465 PHE B 837 REMARK 465 GLN B 838 REMARK 465 GLY B 839 REMARK 465 ASP B 840 REMARK 465 PRO B 841 REMARK 465 THR B 842 REMARK 465 GLY B 1132 REMARK 465 HIS A 825 REMARK 465 HIS A 826 REMARK 465 HIS A 827 REMARK 465 HIS A 828 REMARK 465 HIS A 829 REMARK 465 HIS A 830 REMARK 465 HIS A 831 REMARK 465 HIS A 832 REMARK 465 GLU A 833 REMARK 465 ASN A 834 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 883 CG CD CE NZ REMARK 470 GLU B 890 CG CD OE1 OE2 REMARK 470 ARG B 893 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 923 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 873 20.46 -140.73 REMARK 500 SER B 919 -159.86 -87.65 REMARK 500 HIS B 944 34.13 -94.53 REMARK 500 ARG B 975 -46.78 67.37 REMARK 500 ASP B 976 48.82 -106.16 REMARK 500 PRO B1017 74.29 -69.15 REMARK 500 TRP B1106 35.98 -84.07 REMARK 500 TYR A 868 88.96 -69.83 REMARK 500 ASP A 869 78.45 -119.03 REMARK 500 ARG A 975 -41.62 68.88 REMARK 500 ASP A 976 52.54 -111.61 REMARK 500 TRP A1106 45.49 -89.01 REMARK 500 REMARK 500 REMARK: NULL DBREF 6VNH B 840 1132 UNP O60674 JAK2_HUMAN 840 1132 DBREF 6VNH A 840 1132 UNP O60674 JAK2_HUMAN 840 1132 SEQADV 6VNH HIS B 825 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS B 826 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS B 827 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS B 828 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS B 829 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS B 830 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS B 831 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS B 832 UNP O60674 EXPRESSION TAG SEQADV 6VNH GLU B 833 UNP O60674 EXPRESSION TAG SEQADV 6VNH ASN B 834 UNP O60674 EXPRESSION TAG SEQADV 6VNH LEU B 835 UNP O60674 EXPRESSION TAG SEQADV 6VNH TYR B 836 UNP O60674 EXPRESSION TAG SEQADV 6VNH PHE B 837 UNP O60674 EXPRESSION TAG SEQADV 6VNH GLN B 838 UNP O60674 EXPRESSION TAG SEQADV 6VNH GLY B 839 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 825 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 826 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 827 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 828 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 829 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 830 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 831 UNP O60674 EXPRESSION TAG SEQADV 6VNH HIS A 832 UNP O60674 EXPRESSION TAG SEQADV 6VNH GLU A 833 UNP O60674 EXPRESSION TAG SEQADV 6VNH ASN A 834 UNP O60674 EXPRESSION TAG SEQADV 6VNH LEU A 835 UNP O60674 EXPRESSION TAG SEQADV 6VNH TYR A 836 UNP O60674 EXPRESSION TAG SEQADV 6VNH PHE A 837 UNP O60674 EXPRESSION TAG SEQADV 6VNH GLN A 838 UNP O60674 EXPRESSION TAG SEQADV 6VNH GLY A 839 UNP O60674 EXPRESSION TAG SEQRES 1 B 308 HIS HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 B 308 GLN GLY ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS SEQRES 3 B 308 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 4 B 308 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY SEQRES 5 B 308 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU SEQRES 6 B 308 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU SEQRES 7 B 308 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY SEQRES 8 B 308 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE SEQRES 9 B 308 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU SEQRES 10 B 308 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU SEQRES 11 B 308 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 12 B 308 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG SEQRES 13 B 308 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY SEQRES 14 B 308 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU SEQRES 15 B 308 PTR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE SEQRES 16 B 308 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER SEQRES 17 B 308 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 18 B 308 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO SEQRES 19 B 308 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY SEQRES 20 B 308 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN SEQRES 21 B 308 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU SEQRES 22 B 308 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL SEQRES 23 B 308 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL SEQRES 24 B 308 ASP GLN ILE ARG ASP ASN MET ALA GLY SEQRES 1 A 308 HIS HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 A 308 GLN GLY ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS SEQRES 3 A 308 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 4 A 308 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY SEQRES 5 A 308 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU SEQRES 6 A 308 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU SEQRES 7 A 308 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY SEQRES 8 A 308 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE SEQRES 9 A 308 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU SEQRES 10 A 308 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU SEQRES 11 A 308 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 12 A 308 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG SEQRES 13 A 308 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY SEQRES 14 A 308 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU SEQRES 15 A 308 PTR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE SEQRES 16 A 308 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER SEQRES 17 A 308 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 18 A 308 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO SEQRES 19 A 308 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY SEQRES 20 A 308 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN SEQRES 21 A 308 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU SEQRES 22 A 308 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL SEQRES 23 A 308 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL SEQRES 24 A 308 ASP GLN ILE ARG ASP ASN MET ALA GLY MODRES 6VNH PTR B 1007 TYR MODIFIED RESIDUE MODRES 6VNH PTR A 1007 TYR MODIFIED RESIDUE HET PTR B1007 16 HET PTR A1007 16 HET XZS B1201 39 HET XZS A1201 39 HETNAM PTR O-PHOSPHOTYROSINE HETNAM XZS N-{5-[(2-{[3,5-DIFLUORO-4-(1-METHYLPIPERIDIN-4-YL) HETNAM 2 XZS PHENYL]AMINO}-5-METHYLPYRIMIDIN-4-YL)AMINO]-2- HETNAM 3 XZS FLUOROPHENYL}-2-METHYLPROPANE-2-SULFONAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 XZS 2(C27 H33 F3 N6 O2 S) FORMUL 5 HOH *42(H2 O) HELIX 1 AA1 GLU B 845 ARG B 847 5 3 HELIX 2 AA2 THR B 888 SER B 904 1 17 HELIX 3 AA3 SER B 936 HIS B 944 1 9 HELIX 4 AA4 ASP B 949 LYS B 970 1 22 HELIX 5 AA5 ALA B 1022 GLU B 1028 1 7 HELIX 6 AA6 VAL B 1033 TYR B 1050 1 18 HELIX 7 AA7 GLU B 1052 LYS B 1055 5 4 HELIX 8 AA8 SER B 1056 GLY B 1066 1 11 HELIX 9 AA9 GLY B 1071 ASN B 1084 1 14 HELIX 10 AB1 PRO B 1095 TRP B 1106 1 12 HELIX 11 AB2 ASN B 1109 ARG B 1113 5 5 HELIX 12 AB3 SER B 1115 ALA B 1131 1 17 HELIX 13 AB4 THR A 888 SER A 904 1 17 HELIX 14 AB5 SER A 936 HIS A 944 1 9 HELIX 15 AB6 ASP A 949 LYS A 970 1 22 HELIX 16 AB7 ALA A 978 ARG A 980 5 3 HELIX 17 AB8 PRO A 1017 TYR A 1021 5 5 HELIX 18 AB9 ALA A 1022 GLU A 1028 1 7 HELIX 19 AC1 SER A 1032 THR A 1049 1 18 HELIX 20 AC2 GLU A 1052 LYS A 1055 5 4 HELIX 21 AC3 SER A 1056 GLY A 1066 1 11 HELIX 22 AC4 GLY A 1071 ASN A 1084 1 14 HELIX 23 AC5 PRO A 1095 TRP A 1106 1 12 HELIX 24 AC6 ASN A 1109 ARG A 1113 5 5 HELIX 25 AC7 SER A 1115 GLY A 1132 1 18 SHEET 1 AA1 5 LEU B 849 LYS B 857 0 SHEET 2 AA1 5 GLY B 861 TYR B 868 -1 O MET B 865 N GLN B 853 SHEET 3 AA1 5 GLU B 877 LEU B 884 -1 O VAL B 881 N GLU B 864 SHEET 4 AA1 5 LYS B 926 GLU B 930 -1 O LEU B 927 N LYS B 882 SHEET 5 AA1 5 TYR B 913 CYS B 917 -1 N GLY B 915 O ILE B 928 SHEET 1 AA2 2 TYR B 972 ILE B 973 0 SHEET 2 AA2 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 AA3 2 ILE B 982 ASN B 986 0 SHEET 2 AA3 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 AA4 2 PTR B1007 LYS B1009 0 SHEET 2 AA4 2 LYS B1030 SER B1032 -1 O PHE B1031 N TYR B1008 SHEET 1 AA5 5 LEU A 849 LYS A 857 0 SHEET 2 AA5 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA5 5 GLU A 877 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 AA5 5 ARG A 923 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA5 5 TYR A 913 SER A 919 -1 N GLY A 915 O ILE A 928 SHEET 1 AA6 2 TYR A 972 ILE A 973 0 SHEET 2 AA6 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA7 2 ILE A 982 VAL A 984 0 SHEET 2 AA7 2 VAL A 990 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA8 2 TYR A1008 LYS A1009 0 SHEET 2 AA8 2 LYS A1030 PHE A1031 -1 O PHE A1031 N TYR A1008 LINK C GLU B1006 N PTR B1007 1555 1555 1.33 LINK C PTR B1007 N TYR B1008 1555 1555 1.33 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N TYR A1008 1555 1555 1.33 CISPEP 1 ASN B 859 PHE B 860 0 0.11 CISPEP 2 ALA A 920 GLY A 921 0 -1.11 CRYST1 111.651 111.651 70.565 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008956 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008956 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014171 0.00000